2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Fibrodysplasia Ossificans Progressiva: new trials by email Literature Review of Fibrodysplasia Ossificans Progressiva trials Research Report on Fibrodysplasia Ossificans Progressiva
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Single-Ascending Doses of DS-6016a in Healthy Japanese Subjects DS-6016a, Placebo - Fibrodysplasia Ossificans Progressiva | Phase 1 | Completed | Daiichi Sankyo Co., Ltd. | 48 | 2021-04-01 | 2022-08-03 |
| Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult Subjects Palovarotene, midazolam - Fibrodysplasia Ossificans Progressiva | Phase 1 | Completed | Clementia Pharmaceuticals Inc. | 48 | 2019-01-03 | 2021-04-02 |
Muscular Diseases (2) · Musculoskeletal Diseases (2) · Myositis (2)
Midazolam (1) · Palovarotene (1)
Clementia Pharmaceuticals Inc. (1) · Daiichi Sankyo Co., Ltd. (1)
Japan (1) · United States (1)